The feasibility of delivering a study using the Inspirited Minds faith-based culturally adapted mental health and wellbeing intervention for young Muslim women

ISRCTN ISRCTN17842222
DOI https://doi.org/10.1186/ISRCTN17842222
IRAS number 327432
Secondary identifying numbers Protocol Number: HSK/SF/UH/05701, CPMS 55794, IRAS 327432
Submission date
12/03/2024
Registration date
17/04/2024
Last edited
02/07/2025
Recruitment status
Recruiting
Overall study status
Ongoing
Condition category
Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
The mental health and well-being of young people is a growing issue. Young women are three times more likely to be affected by mental health problems than young men, which can affect the rest of their lives. Mental health issues also affect minority ethnic populations differently, with evidence of increased long-term depression among Muslims compared with others. British Muslims are also less likely to access mental health services, partly because many services do not understand and address their cultural needs. This study will evaluate a programme developed by Inspirited Minds (IM), a Muslim charity that aims to help promote and improve the mental health and well-being of young Muslim women aged 18-24 years old. The IM programme consists of group therapy sessions that have been specially developed to reflect the Muslim faith and culture. The study will investigate whether it is possible to compare the IM programme with a typical mental health programme (like that of the National Health Service) and how well these plans and ways of collecting information work. This ‘feasibility’ study will be conducted in East London and Birmingham communities, in the UK. The project will help understand how the IM programme works, what helps young Muslim women get involved, and their experiences participating. It will then inform a larger study to show if the IM programme improves young women’s mental health and well-being.

Who can participate?
Young Muslim women aged between 18-24 years old who have self-diagnosed or been referred from another source with low mood or mild depression

What does the study involve?
Young Muslim women seeking help for mental health problems from IM will be asked if they would like to take part. Sixty women will be allocated randomly (like flipping a coin) to one of two groups. One will be the culturally tailored IM programme. The other will be a standard mental health programme. The participants will be asked questions about their mental health and well-being. A group or individual discussion will also be conducted to understand their experience of the programmes better and gather the views of the therapists delivering the sessions.

What are the possible benefits and risks of participating?
Participants will benefit from having the opportunity to try a novel intervention and to be involved in research. It is unknown if the intervention is better than usual care (although it is believed to be). There may be some burden, as with most research, because of having to complete questionnaires.

Where is the study run from?
Two locations in East London and Birmingham in community centres/mosques.

When is the study starting and how long is it expected to run for?
March 2024 to February 2026

Who is funding the study?
The National Institute for Health and Care Research (NIHR) Public Health Research (PHR) Programme

Who is the main contact?
Megan Smith (Trial Manager), m.smith25@herts.ac.uk

Study website

Contact information

Prof Daksha Trivedi
Principal Investigator

University of Hertfordshire
College Lane
Hatfield
AL10 9AB
United Kingdom

Phone None provided
Email d.trivedi@herts.ac.uk
Miss Megan Smith
Public, Scientific

University of Hertfordshire
College Lane
Hatfield
AL10 9AB
United Kingdom

Phone +44 (0)1707 286381
Email m.smith25@herts.ac.uk

Study information

Study designTwo-arm cluster randomized controlled feasibility trial
Primary study designInterventional
Secondary study designCluster randomised trial
Study setting(s)Community
Study typeTreatment
Participant information sheet Not available in web format, please use contact details to request a participant information sheet
Scientific titleThe Inspirited Minds Adapted Intervention: Feasibility study of a faith-based culturally adapted intervention to promote mental health and wellbeing in young Muslim women
Study acronymIM-Adapted
Study objectivesThe overall aim of this trial is to establish the feasibility of evaluating a faith-based culturally adapted intervention to promote and improve mental health and wellbeing of young Muslim women in community settings.
Ethics approval(s)

Approved 27/06/2024, University of Hertfordshire Health, Science, Engineering and Technology ECDA (University of Hertfordshire, Hatfield, AL10 9AB, United Kingdom; -; hsetecda@herts.ac.uk), ref: HSK/SF/UH/05701

Health condition(s) or problem(s) studiedLow mood or mild depression
InterventionThis study is a two-arm, cluster-randomised, controlled feasibility trial delivered in groups in two locations in community centres/mosques. Clusters will each comprise 8-10 young women, each attending the same group session. A nested process evaluation will use focus groups/interviews, intervention logs and intervention observations to capture participant and intervention delivery staff’s experiences. Randomisation will be conducted online, stratified by location (London and Birmingham) and ensuring equal numbers in each group.

Eligible participants will be allocated randomly (in groups of approximately 10) to receive one of the following:
1. The IM-Adapted programme - a faith-based culturally adapted peer support group intervention aimed at promoting and improving mental health and well-being and tailored to the specific needs of Muslim communities delivered by an Inspirited Minds specialist trained therapist.
2. Usual psychoeducation group support - includes low-intensity CBT, but excludes specific Islamic messages and tailoring delivered by mental health professionals trained in usual psychoeducational


The Inspirited Minds (IM)-Adapted programme, IM-Adapted, is a faith-based culturally adapted peer support group intervention aimed at promoting and improving mental health and well-being and tailored to the specific needs of Muslim communities. It was co-developed with Muslim service users and therapists. The intervention IM-Adapted recognises the broader cultural identities of young Muslim women and addresses issues of stigma, social structures, and religious explanations for depression, using the best practice approaches. This involves creating positive messages from Islamic teachings relating to positive religious coping. Behavioural components, each linked to behaviour change theories, include activity scheduling to address negative thoughts and improved mood, impact on behaviour, use of positive logs, journalling, goal setting and modelling positive behaviours. The intervention is CBT-based and adapted with Islamic faith messages using cognitive and behavioural underpinnings including insights from GM’s (co-applicant) therapeutic approach with Muslim populations and CBT models used in cultural adaptations. The intervention also uses a place-based community approach by delivering in a mosque or community centre. Participants who receive the intervention will receive the IM-Adapted programme in six weekly sessions (approximately 90 minutes per session) in groups of 8-10. Information will be collected from participants at the start (baseline), at 6 and 24 weeks. This will include questionnaires on depression, anxiety, well-being, quality of life, religious coping, service use and session attendance. Some participants and staff will be asked about their experience in the study.
Intervention typeBehavioural
Primary outcome measureThe feasibility outcomes to determine progression will be:
1. Referral rate measured using the number of people referred for screening via any route by the end of recruitment
2. Number of exclusions measured by the number of participants who do not consent to take part in the study for any reason including those who do not meet the inclusion criteria during screening
3. Recruitment rate recorded as the number of eligible participants who consent to participate in the study by the end of recruitment
2. Retention rates at follow-up recorded as the number of participants who consent to participate and remain in the study until the end of follow-up at 24 weeks post randomisation
3. Participant engagement and adherence measured using the attendance rate at the intervention sessions as a proportion of the total number of sessions at 6 weeks
4. Feasibility, acceptability, barriers and facilitators to interventions and training of therapists measured using focus groups after the 6-week intervention
5. Data quality and follow-up completion rates, including health economic data measured using missing data at 6 weeks and 24 weeks post randomisation
6. Training and delivery model (adherence, engagement, confidence) measured using intervention logs and rated against the adherence checklist at weekly intervention sessions up to 6 weeks
7. Adverse event rate recorded as the frequency, type and severity of event by treatment arm at the end of follow-up at 24 weeks post randomisation
8. The existence of early evidence that the intervention is not inferior to usual care is measured using analysis of primary outcome data collected at baseline and 24 weeks.
9. Feasibility of required sample size and other requirements for future trial measured using sample size calculation computed using follow-up data at 24 weeks.

Further outcome measures are:
1. Distress measured using the Patient Health Questionnaire-9 (PHQ9) at baseline, 6 weeks and 24 weeks
2. Well-being measured using the Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS) at baseline, 6 weeks and 24 weeks
3. Anxiety measured using the Generalised Anxiety Disorder Assessment (GAD-7) at baseline, 6 weeks and 24 weeks
4. Overall health-related quality of life measured using the EQ-5D-5L scale at 6 weeks and 24 weeks
5. Non-health-related resource use for participants of the intervention measured using the Client Service Receipt Inventory (CSRI) at 6 weeks and 24 weeks
6. Religious coping measured using the Brief Religious Coping measure (R-COPE) at baseline, 6 weeks and 24 weeks
Secondary outcome measures1. Health-related quality of life measured using the EuroQol EQ-5D-5L scale at baseline, after 6 weeks and 24 weeks
2. Non-health-related resource use for participants measured using the Client Service Receipt Inventory baseline, after 6 weeks and 24 weeks
3. Religious coping measured using R-Cope baseline, after 6 weeks and 24 weeks
Overall study start date01/03/2024
Completion date28/02/2026

Eligibility

Participant type(s)Service user
Age groupAdult
Lower age limit18 Years
Upper age limit24 Years
SexFemale
Target number of participants60
Key inclusion criteria1. Muslim women aged 18-24 years old self-diagnosed or referred from another source with low mood or mild depression and scoring between 5 and 14 on the Patient Health Questionnaire 9 (PHQ-9) scale (74) (low mood/mild symptoms) and willing to participate in the study.
2. Eligible young women with comorbidities that are not contradictions to the study (e.g., chronic pain)
3. Eligible young women on current treatment with antidepressants, other drugs, or psychological therapy will be included provided these individuals are not excluded because of disease severity.
Key exclusion criteria1. Those who score under 5 or above 14 on the PHQ-9 scale at screening.
2. Those considered unsuitable for whatever reason based on the professional opinion of the mental health professionals during risk assessment (see below). This will include those on current treatment, or with co-morbid conditions that present contraindications to engaging in the study.
3. Those who are identified by the mental health professionals delivering the programme at any point during the conduct of the study as being severely depressed, having psychosis, schizophrenia, or requiring hospitalisation.
4. Participants must be able to read and understand English, although it is not anticipated that this will lead to any exclusions given the age group.
Date of first enrolment19/09/2024
Date of final enrolment30/09/2025

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centres

Birmingham
0
United Kingdom
London
0
United Kingdom

Sponsor information

University of Hertfordshire
University/education

College Lane
Hatfield
AL10 9AB
England
United Kingdom

Phone +44 (0)1707284983
Email research-sponsorship@herts.ac.uk
Website https://www.herts.ac.uk/
ROR logo "ROR" https://ror.org/0267vjk41

Funders

Funder type

Government

Public Health Research Programme
Government organisation / National government
Alternative name(s)
NIHR Public Health Research Programme, PHR
Location
United Kingdom

Results and Publications

Intention to publish date28/02/2027
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
Publication and dissemination planThe main study findings will be published in a peer-reviewed, open-access journal within one year of the end of the trial.
IPD sharing planThe data is being collected for the specific purpose of undertaking a feasibility study. It will not be adequately powered for statistical hypothesis testing and we therefore do not anticipate sharing data, even in an anonymised format, with outside parties. However, requests for data access can be made and will be considered by contacting the Trial Manager (Megan Smith; m.smith25@herts.ac.uk).

Editorial Notes

02/07/2025: The date of final enrolment was changed from 30/06/2025 to 30/09/2025.
21/03/2025: The following changes have been made:
1. The recruitment start date was changed from 31/08/2024 to 19/09/2024.
2. The recruitment end date was changed from 31/03/2025 to 30/06/2025.
06/08/2024: The following changes were made:
1. Protocol number was added.
2. Protocol (not peer reviewed) file was added.
3. The recruitment start date was changed from 01/08/2024 to 31/08/2024.
4. The recruitment end date was changed from 01/03/2025 to 31/03/2025.
09/07/2024: The ethics approval was added.
14/03/2024: Study's existence confirmed by National Institute for Health and Care Research (NIHR) (UK).